Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.6 HKD | -0.60% | +1.59% | +19.42% |
05-01 | Henlius Biotech Logs 1.35 Billion Yuan Revenue in Q1 | MT |
04-26 | Shanghai Henlius Biotech's Cancer Drug Gets the Nod from US FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.42% | 1.16B | |
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-16.69% | 31.09B | |
+52.66% | 24.74B | |
-14.05% | 15.91B | |
-9.12% | 11.96B | |
-15.31% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- 2696 Stock
- News Shanghai Henlius Biotech, Inc.
- Henlius Biotech Wins Nod to Start China Phase 2 Study of Solid Tumor Drug